Tianjin Chase Sun Pharmaceutical Co.,Ltd

Shenzhen Stock Exchange 300026.SZ

Tianjin Chase Sun Pharmaceutical Co.,Ltd Market Capitalization on January 14, 2025: USD 1.51 B

Tianjin Chase Sun Pharmaceutical Co.,Ltd Market Capitalization is USD 1.51 B on January 14, 2025, a -12.82% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.
  • Tianjin Chase Sun Pharmaceutical Co.,Ltd 52-week high Market Capitalization is USD 1.90 B on October 08, 2024, which is 25.52% above the current Market Capitalization.
  • Tianjin Chase Sun Pharmaceutical Co.,Ltd 52-week low Market Capitalization is USD 1.25 B on June 25, 2024, which is -17.11% below the current Market Capitalization.
  • Tianjin Chase Sun Pharmaceutical Co.,Ltd average Market Capitalization for the last 52 weeks is USD 1.54 B.
Key data
Date Market Capitalization Share Price Price to Earnings Ratio (P/E) Price to Sales Ratio (P/S)
Market news
Loading...
Shenzhen Stock Exchange: 300026.SZ

Tianjin Chase Sun Pharmaceutical Co.,Ltd

CEO Ms. Dan Zheng
IPO Date Oct. 30, 2009
Location China
Headquarters No. 20, Quanfa Road
Employees 5,910
Sector Health Care
Industries
Description

Tianjin Chase Sun Pharmaceutical Co.,Ltd engages in the research, development, production, and marketing of various pharmaceutical products in China. The company offers Chinese herb preparation products, medicinal granules, synthetic drugs, biotech drugs, medical apparatus, and Internet based therapy. It is also involved in the research and development of various drugs in the areas of sepsis, pulmonary hypertension, leukemia, cardiovascular and cerebrovascular diseases, arthritis, ischemic stroke, HCV, vascular disease, psychosis, and chemotherapy, as well as anesthesia drugs and immunomodulators. The company was founded in 1996 and is based in Tianjin, China.

StockViz Staff

January 15, 2025

Any question? Send us an email